Combination of Bevacizumab and Everolimus in patients with refractory, progressive intracranial meningioma: Updated results from a phase II trial of the Sarah Cannon Research Institute (CNS 12).

Sajeel Chowdhary

Combination of Bevacizumab and Everolimus in patients with refractory, progressive intracranial meningioma: Updated results from a phase II trial of the Sarah Cannon Research Institute (CNS 12).

Sajeel Chowdhary

Baptist Health South Florida

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Nov 2013
Event	World Federation for Neuro-Oncology (WFNO) and Society for Neuro-Oncology (SNO) Annual Scientific Meeting - San Francisco, CA. Duration: Nov 1 2013 → …

Conference

Conference	World Federation for Neuro-Oncology (WFNO) and Society for Neuro-Oncology (SNO) Annual Scientific Meeting
Period	11/1/13 → …

Disciplines

Medicine and Health Sciences

Cite this

Combination of Bevacizumab and Everolimus in patients with refractory, progressive intracranial meningioma: Updated results from a phase II trial of the Sarah Cannon Research Institute (CNS 12). / Chowdhary, Sajeel.
2013. World Federation for Neuro-Oncology (WFNO) and Society for Neuro-Oncology (SNO) Annual Scientific Meeting.

Research output: Contribution to conference › Presentation

@conference{a1c95235272e406abdbb48c03f43f28d,

title = "Combination of Bevacizumab and Everolimus in patients with refractory, progressive intracranial meningioma: Updated results from a phase II trial of the Sarah Cannon Research Institute (CNS 12).",

author = "Sajeel Chowdhary",

year = "2013",

month = nov,

language = "American English",

note = "World Federation for Neuro-Oncology (WFNO) and Society for Neuro-Oncology (SNO) Annual Scientific Meeting ; Conference date: 01-11-2013",

}

TY - CONF

T1 - Combination of Bevacizumab and Everolimus in patients with refractory, progressive intracranial meningioma: Updated results from a phase II trial of the Sarah Cannon Research Institute (CNS 12).

AU - Chowdhary, Sajeel

PY - 2013/11

Y1 - 2013/11

M3 - Presentation

T2 - World Federation for Neuro-Oncology (WFNO) and Society for Neuro-Oncology (SNO) Annual Scientific Meeting

Y2 - 1 November 2013

ER -